Bio-Rad Labs (BIO) Tops Q1 EPS by 28c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $295.73 -0.87%
Revenue Growth %: -4.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
ETCC, LEDS, DSNY, More
Revenue Growth %: -4.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
ETCC, LEDS, DSNY, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $0.61, $0.28 better than the analyst estimate of $0.33. Revenue for the quarter came in at $472.8 million versus the consensus estimate of $474.6 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens launches transportation coverage, names FedEx a top large-cap pick
- Jewett-Cameron Trading Company Ltd. (JCTC) Reports Q3 Loss of $0.23
- Nuburu prices $38M public offering to fund Tekne deal and debt repayment
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
